Ambic Biolife Private Limited
Manufactures and distributes biodegradable crockery, cutlery, containers, food, and animal feed supplements.
2019 | Meerut, Uttar Pradesh (India) | Active
Ambic Biolife Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.80 Cr
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.50 Cr
- Revenue Growth %
- Profit Growth -788.46%
- Ebitda -758.52%
- Net Worth -1.02%
- Total Assets 50.16%
About Ambic Biolife
Ambic Biolife Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 2019 (Five years and three months 23 days old ). Its registered office is in Meerut, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.80 Cr.
The company currently has active open charges totaling ₹6.50 Cr.
Atul Bansal and Raj Kumar serve as directors at the Company.
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230UP2019PTC123094
- Company No.
123094
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Healthcare
Who are the key members and board of directors at Ambic Biolife?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Bansal  | Director | 06-Nov-2019 | Current |
| Raj Kumar | Director | 06-Nov-2019 | Current |
Financial Performance of Ambic Biolife.
Ambic Biolife Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 788.46% decrease in profit. The company's net worth dipped by a decrease of 1.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ambic Biolife?
In 2023, Ambic Biolife had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ambic Ayurved India Private LimitedAtul Bansal and Raj Kumar are mutual person
Charges (Loans)
Open Charges
₹6.50 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 6.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2022 | Indian Bank | ₹6.50 Cr | Open |
How Many Employees Work at Ambic Biolife?
Unlock and access historical data on people associated with Ambic Biolife, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ambic Biolife, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambic Biolife's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.